As we forge forward through the second half of 2019, many of the catalysts that once seemed over the horizon draw nearer. Here is my list of notable readouts from companies that I follow and/or are on my watch list . . .
About Chris Stang
As a young investor, I focus developing biotech companies. I focus strongly on fundamentals, digging deeper to understand the financial and regulatory position of companies. The biotechnology sector is very volatile, please use caution and do your own additional due diligence before investing. I also secondarily focus on small security and defense companies that provide long-term growth opportunities.